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Sex differences in disease susceptibility due to maternal programming have been reported. We 
previously observed that maternal smoking induced renal disease and neurological changes are 
restricted to males, whilst both male and female offspring develop metabolic disorders. We have also 
found that maternal L-carnitine supplementation during gestation and lactation can significantly 
improve glucose intolerance and hyperlipidaemia in male offspring. This study aimed to determine 
whether such beneficial effects can also occur in female offspring. Balb/c female mice were exposed 
to cigarette smoke (SE) 6 weeks prior to gestation, during gestation and lactation. A subgroup of the 
SE dams was given L-carnitine (1.5mM in drinking water) during gestation and lactation. Female 
offspring were studied at 20 days (weaning) and 13 weeks (adulthood). Maternal smoking increased 
liver weight (%) and blood glucose levels at 20 days, as well as glucose intolerance and plasma 
triglycerides levels at adulthood (P<0.05). The hepatic lipid metabolic marker adipose triglyceride 
lipase was downregulated in the SE offspring at 20 days (P<0.05). At 13 weeks, the hepatic pro-
inflammatory markers IL-1β and TNF-α mRNA expression were upregulated, whilst the anti-
inflammatory marker IL-10 mRNA expression was downregulated in the SE offspring (P<0.05). 
Liver fibrosis was apparent at 20 days and 13 weeks. Maternal L-carnitine supplementation either 
normalised or suppressed all detrimental effects induced by smoke exposure (P<0.05). We conclude 
that maternal L-carnitine supplementation improves metabolic parameters in the female offspring of 
SE dams.   
 






Cigarette smoking is associated with increased systemic inflammation, insulin resistance, glucose 
intolerance and dyslipidemia in humans (1). The association between maternal cigarette smoke 
exposure (SE) and the risk of metabolic disorders in the offspring has also been reported in a mouse 
model of maternal SE (2). Interaction between pro-inflammatory cells and metabolic regulation 
maintains energy homeostasis (3). It has been found that liver lipid accumulation leads to hepatic 
inflammation, which in turn leads to insulin resistance, glucose intolerance and even fibrotic changes 
(4). Maternal SE causes liver oxidative stress damage in the offspring, which may be linked to liver 
microsteatosis (5). As the liver plays a key role in both glucose and lipid metabolism, the above 
evidence suggests that the liver may be the key orchestrator of maternal smoking related substrate 
metabolic disorders in the offspring. 
 
Previous studies suggest that female offspring are relatively protected from adverse in-utero 
exposures. We have demonstrated that female offspring are protected from renal and neurological 
pathology induced by maternal SE in mice (6-8). However, they still developed glucose intolerance 
at adulthood (2), which is consistent with human studies (1). Mattsson and colleagues demonstrated 
that women smoking during pregnancy increases their daughters’ risk of developing obesity and 
gestational diabetes (9). In addition, maternal smoking during the second trimester has been shown 
to change foetal liver markers involved in glucose metabolism in female children, which is clearly 
sex-specific (10). Such changes may contribute to dysregulated glucose and lipid metabolism, and 
ultimately cardiovascular disease in adult females. As the critical organ for substrate metabolism, the 
influx of both dietary glucose and lipids in the liver can induce inflammatory responses resulting in 
insulin resistance and dysregulated lipid metabolism (11). Chronic liver inflammation can also lead 
to fibrosis which can in turn affect liver function (12). To date, the impact of maternal SE on liver 
makers of inflammation, substrate metabolism and fibrosis is unclear. 
 
L-carnitine is an essential nutrient that serves as a biological co-factor involving in transporting long-
chain fatty acid across the inner mitochondrial membrane for β-oxidation and ketones metabolism for 
energy production (13). L-carnitine has also been shown to have an anti-inflammatory effect in the 
liver of mice fed a high-fat diet (14). We have previously shown that L-carnitine supplementation 
during gestation and lactation in the SE dams can improve in-utero cigarette smoke exposure-induced 
brain and renal pathology, as well as glucose intolerance at adulthood in the male offspring (15, 16). 
Although female offspring from the SE dams are resistant to the development of neurological and 





adulthood (2). Thus, this study aimed to evaluate the effect of maternal L-carnitine supplementation 
during gestation and lactation on glucose tolerance and liver markers involved in inflammation, 
substrate metabolism and fibrosis in the female offspring. 
 
Results 
1. Effect of cigarette smoke exposure on the mothers 
The SE dams weighed least among the 3 groups prior to mating (P=0.05 vs Sham) and had a trend to 
a lower weight when the pups were weaned (P=0.08 vs Sham, Supplementary Table 1). No difference 
was found in weight gain after gestation, litter size, or male and female numbers within the litter 
among the three dam groups (Supplementary Table 1). 
 
2. Body and blood parameters in the female mice offspring 
At day 1, female SE offspring (1.28 ± 0.04g) were 8.5% lighter than the Sham offspring (1.40 ± 
0.07g), whereas SE+LC offspring were the heaviest of the 3 groups (1.63 ± 0.05g, P=0.007 vs Sham, 
P=0.0001 vs SE). At 20 days (weaning age), the body weight and liver weight of the female offspring 
were not significantly affected by maternal SE; however, the body weight of the SE groups was 7.8% 
lighter than the Sham group (Table 1). Maternal SE increased the liver weight, expressed as a 
percentage of bodyweight, and random blood glucose levels (P=0.04, Table 1). These parameters 
were normalised in the female SE+LC. At 13 weeks (mature age), body weight, liver weight, 
percentage of liver weight against body weight and non-fasting blood glucose level were similar 
between the SE offspring and Sham offspring (Table 1). Maternal L-carnitine supplementation 
decreased the percentage of liver weight/body weight in the female SE+LC offspring (P=0.03, Table 
1). 
 
Plasma triglycerides (TG) levels were significantly increased in the female SE offspring compared to 
the Sham offspring at both 20 days (P=0.004) and 13 weeks (P=0.0007, Table 1). Plasma non-
esterified fatty acids (NEFA) level were not different among the three groups at any age. There was 
no difference in plasma insulin levels between the SE and Sham groups at 20 days, which showed a 
nearly 20% increase in the SE offspring at 13 weeks, although this was not statistically significant 
(Table 1).  The intraperitoneal glucose tolerance test (IPGTT) demonstrated an Area Under the Curve 
(AUC) value in the SE offspring to be significantly higher than the Sham offspring at 12 weeks 
suggesting that the SE offspring are glucose intolerant (P=0.008, Table 1). Maternal L-carnitine 
treatment did not affect plasma insulin levels in the female offspring at any age. However, it 





value in the SE+LC offspring (P=0.02 vs SE+LC vs SE, Table 1). 
 
2.  Inflammatory markers in the liver  
At 20 days, IL-6 mRNA was tripled by maternal SE (P=0.045 vs Sham, Figure 1b). No differences 
were observed in the liver mRNA expression levels of the other pro-inflammatory markers including 
IL-1β, TNF-α and toll-like receptor (TLR)4 and anti-inflammatory markers IL-10 and IL-22 (Figure 
1). Maternal L-carnitine supplementation only showed a trend to increase the anti-inflammatory 
cytokine IL-10 (P=0.07, SE vs SE+LC Figure 1c). 
 
At 13 weeks, hepatic mRNA expression of IL-1β (P=0.01, Figure 1g) and TNF-α (P=0.04, Figure 1k) 
were upregulated compared with Sham, whilst the anti-inflammatory marker IL-10 (P=0.01 vs Sham, 
Figure 1i) was downregulated in the SE offspring compared to the Sham offspring. IL-6 expression 
was doubled (P=0.08, Figure 1g); while IL-22 was nearly halved (P=0.43, Figure 1j) in the female 
SE offspring, it did not reach statistical significance due to large variance. Maternal L-carnitine 
supplementation normalized liver IL-1β (P=0.03 vs SE), IL-6 (P=0.03 vs SE), IL-22 and TNF-α 
(P=0.03 vs SE) mRNA expression (Figure 1), while IL-10 mRNA expression was increased by 
around 40% in the SE+LC offspring compared with the SE offspring (P=0.07 SE+LC vs SE by t test, 
Figure 1i).    
 
3. Substrate metabolic markers in the liver  
At 20 days, the lipid metabolic marker adipose triglyceride lipase (ATGL) was significantly 
downregulated in the liver of the SE offspring compared to the Sham offspring (P=0.049, Figure 2a). 
Liver mRNA expression of Carnitine palmitoyl transferase (CPT)-1α (Figure 2b), and peroxisome 
proliferator-activated receptor (PPAR)-γ (Figure 2c) had a trend to be reduced by 57% (P=0.08) and 
54% (P=0.06) respectively. Maternal SE had no effect on the mRNA levels of peroxisome 
proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α), forkhead box protein (FOXO)1, 
fatty acid synthase gene (FASN) and glucose transporter 4 (GLUT4; Figure 2). Maternal L-carnitine 
supplementation did not significantly affect the lipid metabolic markers measured at 20 days (Figure 
2).  
 
At 13 weeks, a trend towards increased liver PGC-1α and FASN mRNA expression was found 
(P=0.09 and 0.11 respectively, Figure 2k, 2l). However, ATG, CTP-1α, PPARγ, FOXO-1 and Glut4 
mRNA levels were not changed. Maternal L-carnitine supplementation normalised PGC1α (P=0.04, 





maternal SE, while Glut 4 mRNA expression in SE+LC offspring was less than half of the Sham and 
SE offspring albeit without statistical significance (P=0.18, Figure 2g).  
 
4. Liver Fibrosis  
Cigarette smoking increases the risk of developing fibrosis in multiple organ systems. Both collagen 
I and III protein expression were more than doubled in the livers from the SE offspring at weaning 
(P=0.0006 and P=0.005 SE vs SHAM respectively, Figure 3a,b). Both collagen I and III deposition 
in the SE+LC offspring was however normalized by maternal L-carnitine supplementation (collagen 
I, P=0.005 SE+LC vs SE, Figure 3a; collage III P=0.0003, SE+LC vs SE, Figure 3b).  
 
At 13 weeks, although collagen I protein levels were not changed, collagen III protein expression was 
increased by nearly 3 fold in the SE offspring (P<0.0001, SE vs Sham, Figure 3b). Maternal L-
carnitine supplementation significantly collagen I and III protein levels were significantly reduced 
(collagen I, P=0.0007 SE+LC vs SE; collagen III, P<0.0001 SE+LC vs SE, Figure 3c,d).  
 
Discussion 
Maternal SE prior to and during gestation and lactation significantly increased plasma lipid levels 
and caused glucose intolerance in the female offspring. This was associated with changes in liver 
lipid and glucose metabolic markers as well as increased fibrotic markers. The main finding in this 
study is that maternal L-carnitine supplementation during gestation and lactation can significantly 
ameliorate the adverse SE impacts on glucose intolerance and hyperlipidaemia in the female 
offspring, which is linked to improved metabolic markers in the liver in addition to ameliorating liver 
collagen deposition. 
 
This study showed an increase in the liver weight expressed as a percentage of total body weight at 
weaning in the female SE offspring. A similar trend was observed in their male littermates at 
adulthood (6). This may reflect a catch up growth in less pivotal organs during development, which 
is commonly seen in the situation of intrauterine nutrition restriction such as maternal smoking (1). 
The addictive substance nicotine has been suggested to play a major role, whereas details on how the 
other ~5000 chemicals in the cigarette smoke contribute to such effects individually are largely 
unknown.  
 
In humans, there is a dose-dependent association between prenatal and postnatal SE and the 





old (17). As nicotine is transmittable via breastmilk during breastfeeding, neonatal nicotine exposure 
during lactation may cause insulin resistance and metabolic disorders at adulthood (18). In this study, 
the female offspring from SE mothers developed glucose intolerance and hyperlipidaemia in 
adulthood. This is similar to the metabolic outcome in the male offspring at the same age, who had 
significant glucose intolerance albeit similar body weight as the controls (15). Here at weaning, 
random blood glucose levels were also increased in the female SE offspring, followed by significantly 
increased glucose intolerance at adulthood, suggesting a continuous impairment in systemic glucose 
metabolism. Similar disorders in glucose metabolism have also been found in the male offspring from 
weaning to adulthood (6, 15). It needs to be noted that in the laboratory setting, the rodent’s diet is 
tightly controlled by using nutritionally balanced food, whereas in humans postnatal 
obesogenic/diabetogenic diet is an additional environment insult to the metabolic homeostatic 
regulation. Indeed, children of smokers tend to choose a high caloric diet which further accelerates 
the development of diabetes and related complications (1).    
 
In this study, normal plasma insulin levels with hyperglycaemia in the female SE offspring at 20 days 
are suggestive of insulin resistance. Even at 13 weeks, plasma insulin levels were only marginally 
increased in the female offspring of SE dams (20%) compared to Sham offspring, with significant 
glucose intolerance; whereas in the male littermates, plasma insulin levels were similar to the control 
offspring (15). Maternal nicotine exposure during gestation and lactation has been shown to induce 
permanent β-cell loss and subsequent impairment in glucose tolerance in animal models (19). This 
may explain why there was no significant increase in blood insulin levels in both male and female SE 
offspring at adulthood. Furthermore, glucose intolerance at adulthood also indicates the insensitivity 
of insulin receptors. However, in a previous study we failed to observe a difference in the liver 
response to acute insulin stimulation (2). Since exogenous insulin injection in that study was not as 
physiological as that released by the pancreas in the present study in response to postprandial glucose 
increase, this finding can’t exclude the existence of liver insulin resistance. Previously, maternal 
supplementation of a mixture of antioxidant (vitamin E, coenzyme Q10 and α-lipoic acid) during 
pregnancy and lactation has been shown to increase beta cell proliferation and tissue insulin in 
offspring of nicotine treated rat mothers; however there were no measurements of either blood insulin 
level or glucose level in that study (20).  
 
Inflammation may play a key role in maternal smoking induced glucose intolerance in the offspring. 
Maternal smoking has been shown to change liver inflammatory markers in male but not female 





the mice of SE mothers, however livers from both sexes were combined in this study (21). Here we 
showed significant increase in the liver inflammatory marker expression in female offspring at both 
weaning and adulthood. The association between insulin resistance, hyperglycaemia and increased 
liver inflammatory cytokine production (such as IL-1β and IL-6) has been well documented (22). The 
mechanism is suggested to be via the inhibition of two essential markers involved in cellular glucose 
uptake, PPAR-γ and GLUT4 (23). PPAR-γ regulates glucose homeostasis and insulin sensitivity in a 
tissue and age dependent manner which also involves GLUT4, the insulin dependent glucose 
transporter (24). TNF-α causes insulin resistance and glucose metabolic disorders through multiple 
mechanisms, including the downregulation of GLUT4, the inhibition on insulin signalling cascade, 
the stimulation of lipolysis to elevate free fatty acid level which induces insulin resistance, as well as 
the suppression of PPAR-γ expression and function (23). Here, an upregulation of IL-6 with reduced 
PPAR-γ mRNA expression at weaning may initiate the development of insulin resistance leading to 
glucose intolerance at adulthood; whereas upregulated PPAR-γ at adulthood could be an adaptive 
response to glucose intolerance. The anti-inflammatory cytokine IL-10 acts on macrophages to lower 
the pro-inflammatory cytokines such as TNF-α, and serum IL-10 is reduced in patients with insulin 
resistance (25). Reduced IL-10 mRNA expression in the SE offspring at 13 weeks may suggest an 
attenuation of the anti-inflammatory capacity, in line with the upregulation of pro-inflammatory TNF-
α and IL-1β. Another cytokine IL-22 has been reported to alleviate metabolic disorders, such as 
improving insulin sensitivity and lipid metabolism, decreasing chronic inflammation in the liver,  and 
restoring postprandial glucose clearance in obese mice (26).  The trend reduction in IL-22 mRNA 
expression in the SE offspring at both ages also suggests a reduced capacity to counteract metabolic 
disorders (26).  
 
Smoking is an independent risk factor for liver fibrosis due to cell injury induced by pro-inflammatory 
cytokines, such as IL-1, IL-6 and TNFα (12). Here in adult female offspring, the increase in these 
pro-inflammatory cytokines were indeed accompanied by more collagen deposition. In this study, we 
found that liver collagen I and III proteins were increased in the SE offspring at 20 days, whereas 
only increased collagen III deposition occurred at adulthood.  
 
FOXO1 interacts with PCG1α to suppress hepatic gluconeogenesis in response to insulin, whereas 
the mutation of FOXO1 can demolish such regulation (27). FOXO1 mRNA expression was 
significantly reduced in weaning female offspring by maternal SE with increased blood glucose levels. 
FOXO1 expression was somewhat restored at 13 weeks when there was still significant glucose 





GLUT4 was somehow higher in the SE offspring, which was normalised by maternal L-carnitine 
treatment albeit improved glucose tolerance. This reflects the limitations of mRNA expression which 
does not reflect protein transcription. However, such upregulation may be an adaptive response to 
reduced protein levels, which explained increased AUC level during IPGTT. Therefore, the 
confirmation of protein levels and translocation in response to high glucose challenge is needed in 
future studies. 
 
Smoking is a contributor to hypertriglyceridemia in humans (28). Our results showed that maternal 
SE during pregnancy and lactation led to increased plasma TG in female offspring. The exact 
mechanism for such effect is still unclear. The downregulation of regulators involved in lipid 
metabolism may play a key role. CPT-1α catalases the transportation of long-chain fatty acid into the 
mitochondria for oxidation to synthesise ATP (29); while ATGL regulates liver TG turnover and free 
fatty acid β-oxidation (30). PGC-1α is an essential metabolic switch for substrate metabolic functions 
(31), which also promotes fatty acid oxidation (32). Here both liver CPT-1α and ATGL mRNA 
expression is lower in the SE offspring at 20 days, which could potentially contribute to increased 
blood TG level. At 13 weeks, FASN was high in the female SE offspring, which may lead to increased 
de novo TG synthesis. This is consistent with a previous study using prenatal nicotine injection where 
FASN pathway was upregulated due to epigenetic modification (33). The non-significant increase in 
PGC-1α can be an adaptive response to dysregulated glucose and lipid substrate metabolism.  
 
We have previously demonstrated that maternal L-carnitine supplementation during gestation and 
lactation improves renal and neurological alterations in the male SE offspring of SE dams (15, 16). 
In relation to the focus of this prior study, maternal L-carnitine supplementation also normalised low 
birth weight and kidney underdevelopment, as well as glucose intolerance in the SE male offspring 
in adulthood (15), suggesting a beneficial effect on foetal development and metabolic outcome. In 
the present study, we demonstrated that maternal L-carnitine supplementation also ameliorated the 
effect of maternal SE on low birth weight and increased liver weight in the female offspring with 
normalised glucose homeostasis and lipid profile at adulthood. As such, these effects are similar 
between the male and female offspring from the SE mothers. The unchanged blood insulin level in 
both male and female offspring suggests that L-carnitine may improve peripheral insulin action, but 
not insulin production. In humans, dietary L-carnitine supplementation has been shown to improve 
hepatic insulin resistance by decreasing TNF-α levels and improving lipid profiles (34); The direct 
anti-inflammatory effect of L-carnitine supplement has also been reported in a trial in patients with 





extended anti-inflammatory effects on their liver, evidenced by reduced levels of IL-1β, IL-6, and 
TNF-α expression in adulthood, all key players in insulin resistance. Interestingly, suppression of the 
metabolic regulator IL-22 was also reversed in these female offspring by maternal L-carnitine 
supplementation, which may contribute to normalised pro-inflammatory cytokines and glucose 
metabolism. Previously, L-carnitine has been shown to prevent the development of fibrosis in 
multiple organs, including the liver (36), as well as ameliorate alcohol-induced liver damage (37). In 
this study, maternal L-carnitine supplementation suppressed or normalised liver collagen deposition 
in the weaning and adult female offspring. It needs to be noted that the liver contains a low percentage 
of collagen  - in the order of less than 4%. A second insult that promotes fibrosis such as viral hepatitis 
or non-alcoholic fatty liver disease is required to further determine whether offspring of SE dams are 
linked to high risk of liver cirrhosis, and whether maternal L-carnitine supplementation can prevent 
such changes. 
 
Maternal L-carnitine supplementation normalised blood lipid profiles in the female SE offspring at 
both 20 days and 13 weeks. In rats fed a high fat diet, L-carnitine was shown to reduce liver TG 
synthesis and/or release (38), as well as improve lipid β-oxidation (39). In this study, maternal L-
carnitine nearly normalised the TG lipase ATGL expression at weaning, PCG-1α and FASN 
expression at adulthood, suggesting different markers are involved in lipid dysfunction at different 
ages.   
 
In summary, maternal SE led to glucose intolerance and hyperlipidaemia in the female offspring 
which is associated with abnormal hepatic inflammatory and lipid metabolic markers. This further 
increased their risk of developing fibrosis in adulthood. L-carnitine supplementation during gestation 
and lactation in the mothers can normalise maternal smoking induced metabolic disorders by reducing 
liver inflammation and normalising lipid metabolic and fibrotic markers. This suggests that L-
carnitine supplementation may be beneficial if used by smokers during pregnancy. 
 
Methods 
1. Animal model  
The animal experiments were approved by the Animal Care and Ethics Committee at the University 
of Technology Sydney (ACEC#2011-313A). Female Balb/c mice (6 weeks old, n=36, Animal 
Resources Centre, Perth, Australia) were weighed and divided into two groups, the sham exposure 
group (Sham, n=12) and the SE group (SE, n=24). After 6 weeks of SE, the female mice were mated 





nor the offspring were exposed to cigarette smoke at any time during the study. A subgroup of the SE 
dams was treated with L-carnitine (SE+LC, n=12) via drinking water (1.5mM) starting at the time of 
mating and continued throughout gestation and lactation as previously described (15). 
 
Female offspring were sacrificed at 20 days and at 13 weeks. Briefly, the non-fasted pups were 
weighed and anaesthetized with sodium thiopental (0.1ml/g, i.p., Abbott Australasia, NSW, 
Australia). Blood was collected using heparinised syringes through cardiac puncture. Blood glucose 
was measured. The plasma was separated by centrifugation at 12,000g for 8 minutes and stored at -
20oC for later analysis. Mice were killed by decapitation. The livers were harvested, weighed, snap 
frozen in liquid nitrogen and then stored at -80oC. One offspring from each litter was used for tissue 
analysis. 
 
2. Intraperitoneal glucose tolerance test (IPGTT) 
IPGTT was performed at 12 weeks of age. After 5 hours fasting, a baseline glucose level was taken 
from the tail blood (Accu-Chek, Roche Diagnostics, IN, USA). Then the glucose was administered 
(2 g/kg , n=9-10, ip) and blood glucose levels were measured at 15, 30, 60, and 90 min post-injection 
as previously described (2). The Area Under the Curve (AUC) of the glucose levels was calculated 
for each mouse.  
 
3. Bio-assays 
Plasma TG, NEFA and insulin concentrations were measured using an in-house TG assay (TG 
reagent, Roche Diagnostics, Mannheim, Germany, intra-assay variation 0.5%, inter-assay variation 
3.4%) (40), NEFA-HR kit (WAKO, Osaka, Japan, intra-assay variation 0.75%, inter-assay variation 
4.91%), and Insulin ELISA Kit (Abnova, Taipei, Taiwan, intra and inter assay variation 2.2% and 
5.0%, respectively).  
 
4. Real-time PCR 
Total RNA was extracted from liver tissues using RNeasy plus mini kit (Qiagen, Valencia, CA) 
according to the manufacturers’ instructions. The first strand of cDNA was synthesised from RNA 
using Transcriptor First Strand cDNA Synthesis Kit (Roche Diagnostics, Mannheim, Germany). The 
genes of interest were measured using manufacturer pre-optimized and validated TaqMan® primers 
and probes (Supplementary Table 1, Thermo Fisher Scientific, MA, USA) and Platinum® qPCR 
SuperMix-UDG kit (Thermo Fisher Scientific) using 18s rRNA as the housekeeping gene. The probes 





expression of the Sham group was used as the calibrator, and the values are expressed as fold change 
from control.  
 
5. Immunohistochemistry 
For direct visualisation of collagen fibres, formalin fixed livers were embedded in paraffin and 
sectioned to 5μm. Three non-consecutives sections were collected from each sample (n=6/group). 
Immunohistochemistry was performed with the Dako EnVision+ System-HRP labelled Polymer 
Anti-Rabbit kit (Aglient, CA, USA). In brief, the sections were deparaffinised and treated with xylene 
and decreasing graded ethanol to distilled water for hydration. The sections were then heated in 
pressure cooker (Homemaker, Mulgrave, Australia) for 10 mins with citrate buffer (pH 6.0) followed 
by cooling in water bath for 15 mins for heat-induced epitope retrieval. The sections were blocked 
with peroxidase block solution followed by 5% goat serum in phosphate buffered saline with Tween-
20. The sections were then incubated for 30 minutes with either Collagen I (1:2000, Abcam, 
Cambridge, UK) or III (1:5000, Abcam, Cambridge, UK) diluted in antibody diluent solution 
(Aglient, CA, USA). This was followed by incubated with peroxidase labelled polymer (anti-rabbit) 
solution for 30 minutes. The sections were then incubated with substrate-chromogen for 10 minutes. 
Finally, they are counterstained with hematoxylin and coverslipped. The sections were then scanned 
with NanoZoomer SQ slide scanner (Hamamatsu, Hamamatsu city, Japan). Three fields of images 
were taken at 40X from each section. The images were assessed with (ImageJ National Institute of 
Health, Bethesda, Maryland, USA) to determine the percentage of collagen stain.  
  
6. Statistical analysis 
The results are expressed as mean ± SEM. The differences between the groups were analysed using 
one-way ANOVA followed by Turkey’s post hoc tests (Prism 6, Graphpad CA, USA). Student’s 
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Table 1: Body weight, liver weight, and blood metabolic markers in the female offspring at 20 days 
and 13 weeks 
P 20 Sham SE SE + LC 
Body weight (g) 10.4 ± 0.54 9.59 ±0.18 9.45 ±0.28 
Liver weight (g) 0.45 ± 0.03 0.45 ±0.01 0.43 ±0.02 
Liver/body (%) 4.27 ± 0.08 4.56 ±0.08 * 4.44 ±0.08 
Glucose (mM) 10.8 ± 0.4 12.6 ±0.4 * 11.8 ±0.5 
NEFA (mM) 2.11 ± 0.3 1.95 ± 0.2 1.50 ± 0.1 
TG (mM) 0.86 ± 0.2 1.90 ± 0.2 * 0.66 ± 0.1# 
Insulin (ng/ml) 0.51 ± 0.01 0.52 ± 0.02 0.50 ± 0.02 
Week 13 Sham SE SE + LC 
Body weight (g) 21.7 ± 0.3 20.9 ± 0.3 21.0 ± 0.2 
Liver weight (g) 1.00 ± 0.03 0.96 ± 0.03 0.90 ± 0.02 
Liver/body (%) 4.54 ± 0.06 4.47 ± 0.5 4.29 ± 0.07 # 
Glucose (mM) 10.5 ± 0.4 10.5 ± 0.3 11.2 ± 0.2 
NEFA (mM) 8.87 ± 0.5 8.14 ±0.7 7.18 ± 0.4 
TG (mM) 1.43 ± 0.1 2.34 ± 0.1* 1.43 ± 0.2 # 
Insulin (ng/ml) 0.54 ± 0.10 0.64 ± 0.03 0.64 ± 0.03 
AUC during IPGTT (mM•min) 854 ± 30 1000 ± 25 * 884 ± 28 # 
Results are expressed as Mean ± SEM. n=6-10. The data was analysed by One-way ANOVA followed 
by Turkey’s post hoc tests. * P < 0.05 vs Sham, # P < 0.05 vs SE 
AUC: area under the curve; IPGTT: intraperitoneal glucose tolerance test; NEFA: Non-esterified fatty 








Figure 1: Hepatic mRNA expression of inflammatory markers, IL-1β (a, g), IL-6 (b, h), IL-10 (c, i), 
IL-22 (d, j), TNF-α (e, k), and TLR4 (f, l) in the female offspring at 20 days and 13 weeks of age. 
Results are expressed as mean ± SEM, n=6.  * P < 0.05 SE vs Sham, # P < 0.05 SE+LC vs SE. IL: 
interleukin; SE: mother exposed to cigarette smoke; SE+LC: mother exposed to cigarette smoke and 







Figure 2: Hepatic mRNA expression of lipid metabolic markers, ATGL (a, h), CPT-1α (b, i), PPAR-
γ (c, j), PGC1α (d, k), FASN (e, l), FOXO 1 (f, m), and glucose transporter GLUT 4 (g, n) in the 
female offspring at 20 days and 13 weeks of age. Results are mean ± SEM, n = 6. * P < 0.05 SE vs 
Sham. ATGL: adipose triglyceride lipase; CPT: carnitine palmitoyl transferase; FASN: fatty acid 
synthase gene; FOXO: forkhead box protein; PGC-1α: peroxisome proliferator-activated receptor 
gamma coactivator 1-alpha; PPAR: peroxisome proliferator-activated receptor; SE: mother exposed 
to cigarette smoke; SE+LC: mother exposed to cigarette smoke and treated with L-carnitine during 






Figure 3: Hepatic fibrotic markers collagen I (a) and collagen III (b) staining quantification and 
representative photomicrographs of immunohistochemistry staining (mag 40x, scale bar = 50 µm) in 
the female offspring at 20 days and 13 weeks of age. Results are expressed as mean ± SEM, n = 6. * 
P < 0.05, **P<0.01, SE vs Sham; # P < 0.05, ##  P < 0.01, SE+LC vs SE. SE: mother exposed to 
cigarette smoke; SE+LC: mother exposed to cigarette smoke and treated with L-carnitine during 









Supplementary Table 1: Body weight changes and litter information of the dams. 
 Sham SE SE+LC 
Body weigh at mating (g) 19.1 ± 0.4 17.8 ± 0.5 18.0 ± 0.5 
Body weight at weaning (g) 24.5 ± 0.7 22.5 ± 0.7  23.9 ± 0.8 
Weight gain (g) 0.29 ± 0.03 0.27 ± 0.03 0.33 ± 0.03 
Litter size (pup / litter) 6.2 ± 0.8 5.3 ± 1.0 6.0 ± 1.0 
Male pup / litter 3.5 ± 0.5 2.9 ± 0.7 3.0 ± 0.6 
Female pup / litter 2.6 ± 0.6 2.4 ± 0.6 3.0 ± 0.5 
Results are expressed as Mean ± SEM. n=9-12. The data was analysed by One-way ANOVA followed 
by Turkey’s post hoc tests.  
 
Supplementary Table 2: Probes sequences provided by the manufacture used in rt-PCR (Life 
Technologies, CA, USA). 
Gene NCBI references                  Probe Sequence Assay ID 
18S X03205.1 ACCGCAGCTAGGAATAATGGA 4319413E 
ATGL NM_025802.2 GGCCTGCCTGGGTGAAGCAGGTGCC Mm00503040_m1 
CPT-1α NM_013495.2 TACCGTGAGCAGGTACCTGGAGTCT Mm00550438_m1 
FASN NM_007988.3 CAATTGTGGATGGAGGTATCAACCC Mm00662319_m1 
FOXO 1 NM_001191846 AAGAGTTAGTGAGCAGGCTACATTT Mm00490672_m1 
GLUT 4 NM_009204.2 CTCTGCTGCTGCTGGAACGGGTTCC Mm00436615_m1 
IL-1β NM_008361.3 TCCTTGTGCAAGTGTCTGAAGCAGC Mm01336189_m1 
IL-6 NM_031168.1 ATGAGAAAAGAGTTGTGCAATGGCA Mm00446190_m1 
IL-10 NM_010548.2 GAAGACTTTCTTTCAAACAAAGGAC Mm00439614_m1 
IL-22 NM_016971.2 TGGCCAAGGAGGCCAGCCTTGCAGA Mm00444241_m1 
PGC-1α NM_008904.1 CGCAACATGCTCAAGCCAAACCAAC Mm00447183_m1 
PPAR-γ NM_0011273330.1 ATGCTGTTATGGGTGAAACTCTGG Mm01184322_m1 
TLR4 NM_021297.2 CCCTGCATAGAGGTAGTTCCTAATA Mm00445273_m1 
TNFα NM_013693.2 CCCTCACACTCAGATCATCTTCTCA Mm00443259_g1 
ATGL: adipose triglyceride lipase, CPT: carnitine palmitoyl transferase, FASN: Fatty acid synthase, 
FOXO: Forkhead box protein, GLUT: Glucose transporter, IL: interleukin, PGC: Peroxisome 
proliferator-activated receptor gamma coactivator, PPAR: Peroxisome proliferator-activated 
receptor, TLR: Toll-like receptor, TNF: tumour necrosis factor. 
 
